Middle East Respiratory Syndrome Coronavirus (MERS) Patient Under Investigation (PUI) Form
Form Approved OMB 0920-0004, Exp Date 08/31/2014
For PUI, complete and send this form to eocevent90@cdc.gov (subject line: MERS Form) or fax to 770-488-7107.
If you have questions contact the CDC Emergency Operations Center (EOC) at 770-488-7100.
STATE ID: |
Today’s Date: MM/DD/YY |
County: |
City: |
State: |
|
Interviewer’s name: |
Phone: |
Email: |
|||
Physician’s name: |
Phone/Pager: |
|
PUI Definition—Does the patient have: |
(Please consult CDC website at http://www.cdc.gov/coronavirus/mers/case-def.html) |
||||||
1. Acute respiratory infection with fever (≥ 38oC, 100.4oF) and cough? ☐ Yes ☐ No ☐ Unknown 2. Clinical or radiographic evidence of pneumonia or acute respiratory distress syndrome (ARDS)? ☐ Yes ☐ No ☐ Unknown 3. Travel from the Arabian Peninsula or neighboring countries† 14 days before illness onset? ☐ Yes ☐ No ☐ Unknown If yes, which countries?_________________________________ Date of travel to/from the Middle East: MM/DD/YY|MM/DD/YY |
|||||||
Patient Demographic Information |
|||||||
1. Sex: ☐M ☐F 2. Age:_____ ☐yr ☐mo 3. Residency: ☐US resident ☐non US resident, country:_______________ |
|||||||
Clinical Presentation, History and Risk Factors |
|||||||
4. Date of symptom onset: MM/DD/YY |
|||||||
5. Symptoms (Check all that apply): ☐ Fever ☐ Dry cough ☐ Productive cough ☐ Chills ☐ Sore throat ☐ Headache ☐ Muscle aches ☐ Shortness of breath ☐ Vomiting ☐ Abdominal pain ☐ Diarrhea ☐ Other_________________________ |
|||||||
6. In the 14 days before symptom onset did the patient have close contact with a recent ill traveler from the Arabian Peninsula or neighboring countries†? ☐ Yes ☐ No ☐ Unknown If yes, which countries?_________________________________________ |
|||||||
7. Is the patient (Check all that apply): ☐ Health care worker (HCW) ☐ US military ☐ Flight crew ☐ Other_______________ |
|||||||
8. Concurrent risk factors (Check all that apply): ☐ Immunocompromised ☐Pregnant ☐Unknown ☐Other_____________________________________________________________________________________________________ |
|||||||
Clinical Outcomes |
|||||||
9. Is/Was the patient: a. Hospitalized? b. Admitted to ICU? c. Intubated? |
☐ Yes ☐ No ☐ Unknown If yes, date: MM/YY/DD ☐ Yes ☐ No ☐ Unknown ☐ Yes ☐ No ☐ Unknown |
10. Is/Has patient receiving/received a diagnosis of: |
|||||
Pneumonia? ARDS? Renal failure? |
☐ Yes ☐ No ☐ Unknown ☐ Yes ☐ No ☐ Unknown ☐ Yes ☐ No ☐ Unknown |
||||||
11. Does the patient have a non-MERS etiology for their respiratory illness but has not responded to appropriate therapy? ☐ Yes ☐ No ☐ Unknown |
12. Has the patient died? ☐ Yes ☐ No ☐ Unknown |
||||||
Infection Control |
|||||||
13. When hospitalized, is/was the patient in a: |
14. Are/Were surgical masks being used by the patient during transport? ☐ Yes ☐ No ☐ Unknown |
||||||
a. Negative pressure room? b. Private room? |
☐ Yes ☐ No ☐ Unknown ☐ Yes ☐ No ☐ Unknown |
||||||
15. What personal protective equipment are/were being used by HCW when entering the patient’s room (Check all that apply): ☐ Gloves ☐ Gowns ☐ Eye protection (goggles or face shield) ☐ N95/other form of respiratory protection (e.g., PAPR) ☐ Facemask ☐ Unknown |
Laboratory Testing |
||||||||||||||||||||||||||
Tests Performed |
Results |
Tests Performed |
Results |
|
||||||||||||||||||||||
+ |
̶ |
Pending (Pe) |
Not done |
+ |
̶ |
Pending (Pe) |
Not done |
|||||||||||||||||||
Influenza ☐A ☐B |
|
|
☐ |
☐ |
Streptococcus pneumoniae |
|
|
☐ |
☐ |
|||||||||||||||||
RSV |
|
|
☐ |
☐ |
Legionella pneumophila |
|
|
☐ |
☐ |
|||||||||||||||||
Human metapneumovirus |
|
|
☐ |
☐ |
Blood culture If positive_________________ |
|
|
☐ |
☐ |
|||||||||||||||||
Parainfluenza 1-4 |
|
|
☐ |
☐ |
||||||||||||||||||||||
Adenovirus |
|
|
☐ |
☐ |
Other:____________________ |
|
|
☐ |
☐ |
|||||||||||||||||
MERS Testing |
||||||||||||||||||||||||||
Specimen‡ |
ID # |
Date collected |
State |
Sent to CDC? |
Specimen‡ |
ID # |
Date collected |
State |
Sent to CDC? |
|
||||||||||||||||
+ |
̶ |
Pe |
+ |
̶ |
Pe |
|
||||||||||||||||||||
NP/OP |
|
MM/DD/YY |
|
|
☐ |
☐ |
PF |
|
MM/DD/YY |
|
|
☐ |
☐ |
|
||||||||||||
Sputum |
|
MM/DD/YY |
|
|
☐ |
☐ |
Stool |
|
MM/DD/YY |
|
|
☐ |
☐ |
|
||||||||||||
BAL |
|
MM/DD/YY |
|
|
☐ |
☐ |
Serum |
|
MM/DD/YY |
|
|
☐ |
☐ |
|
||||||||||||
TA |
|
MM/DD/YY |
|
|
☐ |
☐ |
|
|
MM/DD/YY |
|
|
☐ |
☐ |
|
‡NP/OP, Nasopharyngeal/Oropharyngeal swab; BAL, Bronchoalveolar lavage; TA, Tracheal aspirate; PF, Pleural fluid
†Countries considered in the Arabian Peninsula and neighboring include: Bahrain, Iraq, Iran, Israel, Jordan, Kuwait, Lebanon, Oman, Palestinian territories, Qatar, Saudi Arabia, Syria, the United Arab Emirates (UAE), and Yemen.
Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office,1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0004). Version 5.5, 7/3/13
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Lloyd, Spencer (CDC/CGH/DGHA) |
File Modified | 0000-00-00 |
File Created | 2021-01-23 |